Inturai Ventures Corp. announced a non-brokered private placement to raise up to $1,275,000 by issuing 8.5 million units at $0.15 each. Each unit includes one common share and one warrant exercisable at $0.25 within 24 months, allowing investors to benefit from future growth. The funds will support research and development, business expansion, and general working capital. The offering is subject to regulatory approval and includes potential finders' fees for introductions.
Monteverde & Associates PC is investigating the fairness of proposed mergers involving Synaptics (SYNA), Eagle Financial Services (EFSI), Victory Capital Holdings (VCTR), and Centerspace (CSR). Shareholders are urged to consider if the deals are fair...
At the Cisco Partner Summit 2026, Presidio was honored as the Global Innovation Partner of the Year, recognizing its outstanding innovation and success in delivering impactful customer solutions. This award highlights Presidio's commitment to partner...
Presidio was awarded the Global Services and Software Excellence Partner of the Year at the Cisco Partner Summit 2026. This award recognizes Presidio's outstanding innovation and success in delivering solutions that help customers achieve meaningful ...
Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...
Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...
